In conjunction with paclitaxel, blocking macrophage recruitment with CSF1R-signaling antagonists increased the longevity of mice with mammary tumors by decreasing primary tumor development and lowering pulmonary metastasis (59). This evidence concerns the gene CSF1R and neoplasm.